{"id":"probiotic-vivomixx","safety":{"commonSideEffects":[{"rate":null,"effect":"Bloating"},{"rate":null,"effect":"Flatulence"},{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Mild gastrointestinal symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The product contains eight freeze-dried bacterial strains (including Streptococcus thermophilus, Bifidobacterium, and Lactobacillus species) that colonize the intestinal tract. These strains produce short-chain fatty acids, enhance tight junction integrity, and promote anti-inflammatory immune responses, thereby supporting gastrointestinal health and potentially reducing symptoms associated with dysbiosis.","oneSentence":"Vivomixx is a multi-strain probiotic formulation that restores beneficial gut microbiota to improve intestinal barrier function and modulate immune responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:02:39.898Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Irritable bowel syndrome"},{"name":"Inflammatory bowel disease support"},{"name":"Antibiotic-associated diarrhea"},{"name":"General gastrointestinal health maintenance"}]},"trialDetails":[{"nctId":"NCT07380009","phase":"NA","title":"Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy.","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2025-12-12","conditions":"Antibiotic Therapy","enrollment":40},{"nctId":"NCT05922683","phase":"PHASE2","title":"Maternal Probiotic Intervention to Improve Gut Health","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2023-08-09","conditions":"Environmental Enteric Dysfunction, Stunting","enrollment":76},{"nctId":"NCT05501470","phase":"PHASE2","title":"Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal","status":"RECRUITING","sponsor":"Institut Pasteur de Dakar","startDate":"2024-06-06","conditions":"Environmental Enteric Dysfunction","enrollment":76},{"nctId":"NCT05767450","phase":"NA","title":"Intervention on New Onset-T1D Children","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2022-12-16","conditions":"Type 1 Diabetes","enrollment":60},{"nctId":"NCT06592976","phase":"NA","title":"Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with Endometriosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2020-10-21","conditions":"Endometriosis, Bacterial Vaginosis, Healthy Volunteer","enrollment":123},{"nctId":"NCT03906578","phase":"NA","title":"Effects of a Probiotic in Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2019-09-02","conditions":"Hypertension","enrollment":46},{"nctId":"NCT06087874","phase":"PHASE2","title":"Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-03-23","conditions":"Neonatal Jaundice, Microtia, Pregnancy Related","enrollment":94},{"nctId":"NCT04175223","phase":"NA","title":"Impact of Probiotics in HIV-positive Patients With Neurocognitive Disorders","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2019-09-19","conditions":"HIV, Neurocognitive Disorders","enrollment":32},{"nctId":"NCT05920018","phase":"NA","title":"Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis","status":"RECRUITING","sponsor":"Universität Münster","startDate":"2023-10-02","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":100},{"nctId":"NCT04243148","phase":"NA","title":"Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-05-13","conditions":"Cirrhosis of the Liver, Sarcopenia, Frailty Syndrome","enrollment":37},{"nctId":"NCT06196450","phase":"PHASE2","title":"Maternal Probiotic Intervention to Improve Gut Health","status":"UNKNOWN","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2023-06-22","conditions":"Environmental Enteric Dysfunction, Gut Microbiota Dysbiosis","enrollment":76},{"nctId":"NCT05608928","phase":"PHASE2","title":"Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia","status":"UNKNOWN","sponsor":"Tropical Gastroenterology & Nutrition Group (TROPGAN)","startDate":"2022-12-01","conditions":"Environmental Enteropathy","enrollment":76},{"nctId":"NCT04769687","phase":"PHASE2","title":"Symbiotics and Systemic Inflammation in Chronic Kidney Disease","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2020-11-21","conditions":"Chronic Renal Failure, Diabete Type 2, Systemic Inflammation","enrollment":62},{"nctId":"NCT02971787","phase":"NA","title":"Salt Intake and Lactobacillus Abundance","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2016-11","conditions":"Healthy Volunteers, Probiotics, Sodium","enrollment":8},{"nctId":"NCT05083572","phase":"PHASE4","title":"Effect of Probiotic on Gut Microbiome and Bacterial Translocation in Healthy Asian Volunteers","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2021-03-10","conditions":"Dysbiosis","enrollment":32},{"nctId":"NCT03369431","phase":"NA","title":"Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder","status":"COMPLETED","sponsor":"University College, London","startDate":"2018-02-01","conditions":"Autism Spectrum Disorder","enrollment":69},{"nctId":"NCT02957591","phase":"NA","title":"Probiotic Supplementation in Severe Depression","status":"COMPLETED","sponsor":"Psychiatric Hospital of the University of Basel","startDate":"2017-03-24","conditions":"Severe Depression","enrollment":60},{"nctId":"NCT04431934","phase":"NA","title":"Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL)","status":"UNKNOWN","sponsor":"Hospital Clinic of Barcelona","startDate":"2020-11-16","conditions":"CARRIER STATE","enrollment":437},{"nctId":"NCT04160767","phase":"PHASE4","title":"Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients","status":"UNKNOWN","sponsor":"University of Milan","startDate":"2019-01-30","conditions":"Celiac Disease","enrollment":90},{"nctId":"NCT03478527","phase":"NA","title":"Probiotics, Brain Structure and Psychological Variables","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2018-01-08","conditions":"Depressive Symptoms, Anxiety, Stress","enrollment":59},{"nctId":"NCT03109587","phase":"NA","title":"Pilot Study of Probiotics in Pre-diabetic Adolescents","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2018-06-01","conditions":"Obesity, Childhood","enrollment":16},{"nctId":"NCT02508844","phase":"PHASE4","title":"Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2015-04","conditions":"Pregnancy, Obesity, Gestational Diabetes Mellitus","enrollment":50},{"nctId":"NCT04099433","phase":"NA","title":"Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2019-03-01","conditions":"HIV, Anal Dysplasia","enrollment":40},{"nctId":"NCT04006977","phase":"NA","title":"Multistrain Probiotics Reduces UC Depression and Anxiety Scores","status":"UNKNOWN","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2019-10","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT03860415","phase":"NA","title":"Can Probiotic Vivomixx Eradicate Colonization With ESBL?","status":"COMPLETED","sponsor":"Lund University","startDate":"2017-02-01","conditions":"Antibiotic Resistant Infection","enrollment":80},{"nctId":"NCT02708901","phase":"NA","title":"Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters","status":"COMPLETED","sponsor":"IRCCS Fondazione Stella Maris","startDate":"2015-11","conditions":"Autism Spectrum Disorder","enrollment":85},{"nctId":"NCT03518268","phase":"PHASE1, PHASE2","title":"Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2019-01","conditions":"Breast Cancer, Osteoporosis, Osteopenia","enrollment":40},{"nctId":"NCT01804959","phase":"PHASE2","title":"Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2013-05","conditions":"Systemic Sclerosis","enrollment":40},{"nctId":"NCT03236090","phase":"NA","title":"Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis","status":"WITHDRAWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2017-07-15","conditions":"Cirrhosis, Liver","enrollment":""},{"nctId":"NCT02552862","phase":"PHASE3","title":"Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)","status":"WITHDRAWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2016-09","conditions":"Spontaneous Bacterial Peritonitis","enrollment":""},{"nctId":"NCT02768818","phase":"PHASE3","title":"Modulation of the Intestinal Flora With the Probiotic VIVOMIXX™ in Pregnant Women at Risk of Metabolic Complications","status":"UNKNOWN","sponsor":"University of Modena and Reggio Emilia","startDate":"2016-01","conditions":"Gestational Diabetes Mellitus in Pregnancy, Diet- Controlled, Exercise Addiction, High-Risk Pregnancy","enrollment":205}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Probiotic Vivomixx","genericName":"Probiotic Vivomixx","companyName":"University of Milan","companyId":"university-of-milan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vivomixx is a multi-strain probiotic formulation that restores beneficial gut microbiota to improve intestinal barrier function and modulate immune responses. Used for Irritable bowel syndrome, Inflammatory bowel disease support, Antibiotic-associated diarrhea.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}